New FDA head criticized for role in expanding availability o

WASHINGTON (CNS) -- Pro-life leaders criticized the U.S. Senate's Feb. 15 confirmation of Dr. Robert Califf as President Joe Biden's commissioner of the Food and Drug Administration, taking issue with Califf's role in the agency expanding the availability of the drug protocol used for chemical abortions.

Related Keywords

United States , Maryland , Washington , America , Maggie Hassan , Janet Woodcock , Joe Biden , Theodore Chuang , Susanb Anthony , Marjorie Dannenfelser , Joe Manchin , Jeanne Mancini , Us Department Of Health , Defense Fund , Drug Administration , Us Supreme Court , American College Of Obstetricians , Us Senate Feb , Life Sciences , Alphabet Inc , Centessa Pharmaceuticals , Robert Califf , President Joe Biden , Life Education , Judge Theodore Chuang , American College , Human Services , Bloomberg Law , Verily Life Sciences , Catholic News , News , Atholic , Ardinalo Malley , Boston , Rchdiocese Of Boston , Church , Pope , Rancis , Enedict Xvi , Ohn Paul Ii , Vatican , Holy See ,